Company Monitoring Page for Vertex

latest headlines for company on cafepharma

J&J Open to Expanding Hepatitis C Collaboration With Vertex
Bloomberg
Fri, 04/20/12 - 10:35 am
Tags:
hepatitis C, JNJ, Vertex
Vertex: Watch New Hepatitis C Drug
Seeking Alpha
Wed, 04/11/12 - 11:46 am
Tags:
hepatitis C, Vertex, Incivek, Abbott Laboratories, Bristol-Myers Squibb, Gilead
3 Strong Biotech Stocks Better Than Keryx
Seeking Alpha
Fri, 04/6/12 - 11:13 am
Tags:
Keryx, Vertex, Achillion, Dendreon
How Much Further Can Rare Diseases Carry BioMarin?
Seeking Alpha
Thu, 03/29/12 - 05:19 pm
Tags:
Biomarin, Amicus Therapeutics, Sanofi, Vertex
EASL Gives Wall Street's Privileged Investors Sneaky Preview to Key Hep C Data
TheStreet.com
Tue, 03/20/12 - 11:47 am
Tags:
hepatitis C, EASL, Gilead, Bristol-Myers Squibb, Abbott Laboratories, Vertex, Merck
Recent FDA Approval Makes Vertex A Ripe Target For Takeover
Seeking Alpha
Thu, 03/1/12 - 12:45 pm
Tags:
FDA, Vertex, M&A, Kalydeco, cystic fibrosis
Don't Count Vertex Out Just Yet
Motley Fool
Wed, 02/29/12 - 10:09 am
Tags:
Vertex, Incivek, hepatitis C, Merck, Roche
Hepatitis C Remains A Hot Play
Seeking Alpha
Mon, 02/27/12 - 12:01 pm
Tags:
hepatitis C, Bristol-Myers Squibb, Novartis, Gilead, Inhibitex, Merck, Vertex, Pharmasset, Enanta
Vertex: The Best Of The Companies Investing In Cystic Fibrosis
Seeking Alpha
Tue, 02/21/12 - 10:39 am
Tags:
cystic fibrosis, Vertex, Gilead, Novartis, Sanofi
Friday's Overreaction Provides Great Entry Point For Gilead
Seeking Alpha
Tue, 02/21/12 - 09:01 am
Tags:
Gilead, Vertex, hepatitis C, Pharmasset, PSI-7977
Achillion, Vertex rally on Gilead's woes
Marketwatch
Fri, 02/17/12 - 01:17 pm
Tags:
Vertex, Gilead, Achillion, GS-7977, protease inhibitors, hepatitis C
Gilead, Vertex and the Mystery of Missing Hep C Patients
TheStreet.com
Mon, 02/13/12 - 10:25 am
Tags:
Vertex, hepatitis C, Gilead
Vertex Pharma reports 4th-quarter profit as sales of hepatitis C drug Incivek reach $456.8M
Yahoo/AP
Fri, 02/3/12 - 09:46 am
Tags:
Vertex, hepatitis C, Incivek, earnings
Vertex Pharmaceuticals Inc. Fourth Quarter Earnings Sneak Peek
Yahoo/Wall St Cheat Sheet
Mon, 01/30/12 - 10:57 am
Tags:
Vertex, earnings
Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race
Xconomy
Tue, 01/24/12 - 10:56 am
Tags:
Allos, Vertex, hepatitis C, Telaprevir, Incivek
3 Lessons From the J.P. Morgan Health-Care Confab
Motley Fool
Mon, 01/16/12 - 10:43 am
Tags:
SOMA, Regeneron, Vertex, Gilead, GSK, Biocryst, Dendreon, InterMune
Analyzing 5 Biotech Stocks And Their Takeover Potential
Seeking Alpha
Fri, 01/13/12 - 10:33 am
Tags:
Abbott Laboratories, Achillion, Alexion, Bristol-Myers Squibb, Gilead, GSK, Human Genome Sciences, Indenix, Inhibitex, JNJ, Pfizer, Vertex, Pharmasset
Biotech Investors Buoyed By Signs Of Speedier Drug Launches
Seeking Alpha
Mon, 01/9/12 - 10:40 am
Tags:
drug launches, Dendreon, Incyte, Human Genome Sciences, Regeneron, Seattle Genetics, Vertex
Biotech 2012 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/4/12 - 10:22 am
Tags:
Celgene, Vivus, Dendreon, Gilead, Incyte, YM BioSciences, ONYX Pharmaceuticals, Seattle Genetics, Vertex, Amarin, Biomarin, Biogen Idec, Regeneron, Merck KGaA, Human Genome Sciences, Clovis Oncology, Roche, Ariad, Immunogen, Medivation, Geron, InterMune, Indenix, Amag Pharmaceuticals, Mesoblast, Arena, MannKind, Keryx, Spectrum Pharmaceuticals
Biotech Stock Mailbag: Most Important Events for 2012
TheStreet.com
Fri, 12/23/11 - 08:56 am
Tags:
Oncothyreon, Keryx, Vical, Aeterna Zentaris, Eli Lilly, JNJ, Elan, Celgene, Pfizer, Gilead, Pharmasset, Threshold Pharmaceuticals, Celldex, Amgen, BioVex, Aveo Pharmaceutical, Amylin, Alkermes, Vertex, Cell Therapeutics, Amarin, ONYX Pharmaceuticals, Vivus

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.